Child enrichment can cost Rs 1 lakh/year: Here’s how to fund your child’s preschool activity classes—from dance, music to phonicsFrom phonics to piano, music to drama, activity classes for pre-schoolers are growing fast—and so is the cost of raising a well-rounded chi...
27 Apr, 2026, 10.46 AM IST
Is the Indian middle class dream over? Saurabh Mukherjea on the 3 forces crushing your futureIndia's middle class is in deep trouble. Education no longer guarantees prosperity. Jobs are disappearing, especially in IT. Wages are not ...
21 Apr, 2026, 09.52 AM IST
Enzyme Office Spaces signs 3.5 lakh sq ft in Bengaluru, expands footprintEnzyme Office Spaces is expanding its presence in Bengaluru by leasing 3.5 lakh square feet. This move will add approximately 5,000 seats a...
31 Mar, 2026, 01.00 PM IST
Lux Capital warns portfolio startups to brace for market risksLux Capital warned its portfolio founders to prepare for potential risks, noting “signals suggest something is off” as bond yields fell des...
04 Mar, 2026, 03.24 PM IST
Infosys shares in focus following strategic AI partnership with CognitionThe integration of Infosys Topaz Fabric and Cognition’s autonomous engineering tech is expected to fast-track software development and mode...
08 Jan, 2026, 09.43 AM IST
Infosys, Cognition join hands to push AI software engineer 'Devin' across global enterprisesInfosys and Cognition announced a partnership to scale latter's AI coding engineer, Devin, to organisations. The collaboration will deploy ...
07 Jan, 2026, 07.50 PM IST
How sleep impacts your health and productivity, is it better to stay awake till late night or get up early?It unpacks the science behind chronotypes - the biological wiring that determines whether you naturally wake up early or stay up late - and...
19 Nov, 2025, 08.17 PM IST
NYT Connections Hints and Answers November 10: Monday Puzzle #883 challenges playersNYT Connections: The New York Times’ Connections puzzle, introduced after the success of Wordle, challenges players to organize 16 seemingl...
10 Nov, 2025, 06.06 PM IST
MIT study reveals chilling cognitive cost of ChatGPT on children: What can parents do?A recent MIT Media Lab study has raised concerns about the cognitive impact of AI use among young people. Researchers found that frequent r...
13 Oct, 2025, 07.07 PM IST
MIT researchers say using ChatGPT can rot your brain, truth is little more complicatedOver the course of four months, the MIT team asked 54 adults to write a series of three essays using either AI (ChatGPT), a search engine, ...
08 Jul, 2025, 12.45 PM IST
Losing jobs to AI was just the start, Gen Z is outsourcing emotions too. New reports warn of a looming crisisA recent MIT study shows prolonged AI use may reduce cognitive engagement and critical thinking, raising concerns about “cognitive debt.” A...
27 Jun, 2025, 09.22 PM IST
What is a NASA nap? Space agency reveals the perfect nap length that astronauts and pilots take, which you can emulate; here's all about itNASA research shows that a brief nap can improve alertness, memory, and performance without causing grogginess. This technique, known as a ...
18 Feb, 2025, 09.37 PM IST
Top Nifty IT stocks analysts recommend to buy and holdThe Q4 earning season will get started with TCS announcing its result. This will bring IT stocks back in the limelight and action is bound ...
11 Apr, 2023, 12.09 PM IST
You can't catch up on days of sleep. Being deprived of snooze time may cause long-lasting brain damageSleep deprivation can increase the risk of neurodegenerative disorders like Alzheimer's disease.
11 Jul, 2022, 07.02 PM IST
Why basic income security is essential for financial well beingReal scarcity of resources is a different tough state. Research shows that families that do not have enough to finance even their basic nee...
12 Jul, 2021, 06.30 AM IST
- Suven to raise funds for phase II trials of Alzheimer’s molecule
Suven Life Sciences’ molecule for Alzheimer’s disease will soon enter phase II trials.
08 Apr, 2009, 01.12 AM IST
- Suven all set to raise funds for Alzheimer trials
Suven Life Sciences' molecule for Alzheimer's disease will soon enter phase two trials. Hyderabad-based contract research company is in pro...
07 Apr, 2009, 01.22 AM IST